Residual risk and waste in donated blood with pooled nucleic acid testing

Statistics in Medicine

Volumn 35, Issue 28, 2016, Pages 5283-5301

  Aprahamian, Hrayer ^a   Bish, Douglas R ^a   Bish, Ebru K ^a  

^a State University   (United States)

Author keywords

blood screening; dilution effect; imperfect tests; pooled testing; risk estimation

Indexed keywords

ACCURACY; ARTICLE; BIOASSAY; BLOOD DONOR; BLOOD SAMPLING; HEPATITIS B; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MEDICAL PARAMETERS; NUCLEIC ACID ANALYSIS; RESIDUAL RISK; RESIDUAL WASTE; SCREENING TEST; SENSITIVITY ANALYSIS; VIRUS LOAD; VIRUS TRANSMISSION; HEPACIVIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; RISK ASSESSMENT; VIROLOGY; VIRUS INFECTION;

NUCLEIC ACID;

BLOOD DONORS; HEPACIVIRUS; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; NUCLEIC ACIDS; RISK ASSESSMENT; VIRUS DISEASES;

EID: 84989244165     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.7066     Document Type: Article

References (58)

1. Food Administration D. FDA, complete list of donor screening assays for infectious agents and hiv diagnostic assays. Available from: http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm080466.htm#TOC [Accessed on 9 July 2015].
2. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45(2): 254–264.
3. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003; 43(6): 788–798.
4. Busch MP. HIV, HBV and HCV: new developments related to transfusion safety. Vox Sanguinis 2000; 78: 253–256.
5. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17(13): 1871–1879.
6. Glynn SA, Wright DJ, Kleinman SH, Hirschkorn D, Tu Y, Heldebrant C, Smith R, Giachetti C, Gallarda J, Busch MP. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005; 45(6): 994–1002.
7. Weusten J, van Drimmelen H, Lelie N. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion 2002; 42(5): 537–548.
8. Weusten J, Vermeulen M, van Drimmelen H, Lelie N. Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion 2011; 51(1): 203–215.
9. Daar ES, Little S, Pitt J, Santangelo J, Ho P, Harawa M, Kerndt P, Giorgi JV, Bai J, Gaut P, Richman DD, Mandel S, Nichols S. Diagnosis of primary HIV-1 infection. Annals of Internal Medicine 2001; 134(1): 25–29.
10. Dineva MA, Mahilum-Tapay L, Lee H. Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings. Analyst 2007; 132(12): 1193–1199.
11. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002; 16(8): 1119–1129.
12. Kim HY, Hudgens MG, Dreyfuss JM, Westreich DJ, Pilcher CD. Comparison of group testing algorithms for case identification in the presence of test error. Biometrics 2007; 63(4): 1152–1163.
13. Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003; 43(6): 721–729.
14. Rauber C, Robertson K. Rising Price of Blood Puts Squeeze on Hospitals. San Francisco Business Times, 2007.
15. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50(4): 753–765.
16. Arnold SF. Generalized group testing procedures. The Annals of Statistics 1977; 5(6): 1170–1182.
17. Burns KC, Mauro CA. Group testing with test error as a function of concentration. Communications in Statistics-Theory and Methods 1987; 16(10): 2821–2837.
18. Hwang FK. Group testing with a dilution effect. Biometrika 1976; 63(3): 671–680.
19. Wein LM, Zenios SA. Pooled testing for HIV screening: capturing the dilution effect. Operations Research 1996; 44(4): 543–569.
20. Bish EK, Ragavan PK, Bish DR, Slonim AD, Stramer SL. A probabilistic method for the estimation of residual risk in donated blood. Biostatistics 2014; 15(4): 620–635.
21. AuBuchon JP, Birkmeyer JD, Busch MP. Safety of the blood supply in the United States: opportunities and controversies. Annals of Internal Medicine 1997; 127(10): 904–909.
22. Brandeau ML, Sainfort F, Pierskalla WP. Operations Research and Health Care: A Handbook of Methods and Applications, Vol. 70. Kluwer Academic Publishers: Boston, Massachusetts, 2004.
23. Sodahlon YK, Segbena A, Prince-David M, Gbo KA, Fargier MP, North ML, Malvy DJ. Blood transfusion safety in a limited resources setting: the elaboration of a rational National Blood Policy in Togo. Sante Montrouge, France 2003; 14(2): 115–120.
24. McMahan CS, Tebbs JM, Bilder CR. Regression models for group testing data with pool dilution effects. Biostatistics 2013; 14(2): 284–298.
25. Alliance EB. Blood, tissues and cells from human origin. Available from: http://www.europeanbloodalliance.eu/wp-content/uploads/2013/04/eba_online.pdf [Accessed on 19 July 2015].
26. American Red Cross. Details of tests performed for different infectious agents. Available from: http://www.redcrossblood.org/learn-about-blood/what-happens-donated-blood/blood-testing [Accessed on 9 July 2015].
27. Dorfman R. The detection of defective members of large populations. The Annals of Mathematical Statistics 1943; 14(4): 436–440.
28. Bilder CR, Tebbs JM. Pooled-testing procedures for screening high volume clinical specimens in heterogeneous populations. Statistics in Medicine 2012; 31(27): 3261–3268.
29. Johnson NL, Kotz S, Wu XZ. Inspection Errors for Attributes in Quality Control, Vol. 44. CRC Press: London, 1991.
30. Hudgens MG, Kim HY. Optimal configuration of a square array group testing algorithm. Communications in Statistics-Theory and Methods 2011; 40(3): 436–448.
31. Cowling DW, Gardner IA, Johnson WO. Comparison of methods for estimation of individual-level prevalence based on pooled samples. Preventive Veterinary Medicine 1999; 39(3): 211–225.
32. Speybroeck N, Williams CJ, Lafia KB, Devleesschauwer B, Berkvens D. Estimating the prevalence of infections in vector populations using pools of samples. Medical and Veterinary Entomology 2012; 26(4): 361–371.
33. Tu XM, Litvak E, Pagano M. Screening tests: can we get more by doing less?Statistics in Medicine 1994; 13(19-20): 1905–1919.
34. Tu XM, Litvak E, Pagano M. On the informativeness and accuracy of pooled testing in estimating prevalence of a rare disease: application to HIV screening. Biometrika 1995; 82(2): 287–297.
35. Zenios SA, Wein LM. Pooled testing for HIV prevalence estimation: exploiting the dilution effect. Statistics in Medicine 1998; 17(13): 1447–1467.
36. Zhang Z, Liu C, Kim S, Liu A. Prevalence estimation subject to misclassification: the mis-substitution bias and some remedies. Statistics in Medicine 2014; 33(25): 4482–4500.
37. Amemiya CT, Alegria-Hartman MJ, Aslanidis C, Chen C, Nikolic J, Gingrich JC, De Jong P. A two-dimensional YAC pooling strategy for library screening via STS and Alu-PCR methods. Nucleic Acids Research 1992; 20(10): 2559–2563.
38. Barillot E, Lacroix B, Cohen D. Theoretical analysis of library screening using an N-dimensional pooling strategy. Nucleic Acids Research 1991; 19(22): 6241–6247.
39. Bruno WJ, Knill E, Balding DJ, Bruce DC, Doggett NA, Sawhill WW, Stallings RL, Whittaker CC, Torney DC. Efficient pooling designs for library screening. Genomics 1995; 26(1): 21–30.
40. Berger T, Mandell JW, Subrahmanya P. Maximally efficient two-stage screening. Biometrics 2000; 56(3): 833–840.
41. Hedt BL, Pagano M. A matrix pooling algorithm for disease detection, Working paper 57, Harvard University Biostatistics Working Paper Series, 2008.
42. Phatarfod RM, Sudbury A. The use of a square array scheme in blood testing. Statistics in Medicine 1994; 13(22): 2337–2343.
43. Kim HY, Hudgens MG. Three-dimensional array-based group testing algorithms. Biometrics 2009; 65(3): 903–910.
44. Habtesllassie YG, Haines LM, Mwambi HG, Odhiambo JW. Array-based schemes for group screening with test errors which incorporate a concentration effect. Journal of Statistical Planning and Inference 2015; 167: 41–57.
45. Janssen MP, Over J, Van Der Poel CL, Cuijpers HTM, Van Hout B. A probabilistic model for analyzing viral risks of plasma-derived medicinal products. Transfusion 2008; 48(1): 153–162.
46. Kleinman S, Busch MP, Korelitz JJ, Schreiber GB. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Transfusion Medicine Reviews 1997; 11(3): 155–172.
47. Van Hulst M, Hubben GA, Sagoe KW, Promwong C, Permpikul P, Fongsatitkul L, Glynn DM, Sibinga CT, Postma MJ. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands. Transfusion 2009; 49(12): 2729–2742.
48. Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Dodd RY, Kleinman SH. Comparative analysis of triplex nucleic acid test assays in United States blood donors. Transfusion 2013; 53(10pt2): 2525–2537.
49. Bish DR, Bish EK, Xie SR, Slonim AD. Optimal selection of screening assays for infectious agents in donated blood. IIE Transactions on Healthcare Systems Engineering 2011; 1(2): 67–90.
50. Pepe MS. The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford University Press: New York, 2003.
51. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009; 49(6): 1115–1125.
52. Service SouthAfricanNationalBlood. Haemovigilance report 2014. Available from: http://www.sanbs.org.za/PDFDocuments/services/Haemovigilance/SANBS-HV-Report2014_WebVersion.pdf [Accessed on 1 March 2015].
53. Walkley A. Africa: HIV transmission via transfusions in continent remains high. Available from: http://allafrica.com/stories/201001050140.html [Accessed on 3 March 2016].
54. El Amine H, Bish EK, Bish DR. Robust post-donation blood screening under prevalence rate uncertainty. Working paper, Department of Industrial and Systems Engineering, Virginia Tech, Blacksburg, VA.
55. Marshall D, Kleinman S, Wong J, AuBuchon J, Grima D, Kulin N, Weinstein M. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sanguinis 2004; 86(1): 28–40.
56. Bish EK, Moritz ED, El-Amine H, Bish DR, Stramer SL. Cost-effectiveness of Babesia microti antibody and nucleic acid blood donation screening using results from prospective investigational studies. Transfusion 2015; 55(9): 2256–2271.
57. Simon MS, Leff JA, Pandya A, Cushing M, Shaz BH, Calfee DP, Schackman BR, Mushlin AI. Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion 2014; 54(3pt2): 889–899.
58. United States Census Bureau. Age and sex composition in the United States, 2012. Available from: http://www.census.gov/population/age/data/2012comp.html [Accessed on 29 January 2016].